$MCET Multicell Immunotherapeutics, Inc have become CONSENT to Proceed Before a US Magistrate Judge versus GT Biopharma, Inc., and its predecessors Oxis International, Inc. and Oxis Biotech, Inc.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.